-
@ Paula Bogan
2025-06-02 11:10:43Data NVG-291 Chronic Spinal Pharma of from its Topline 1b/2a in Clinical Evaluating Trial Reports the Phase Positive Cord NervGen Injury https://financialpost.com/globe-newswire/nervgen-pharma-reports-positive-topline-data-from-the-chronic-cohort-of-its-phase-1b-2a-clinical-trial-evaluating-nvg-291-in-spinal-cord-injury Cohort